Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis
NEPHROLOGY, cilt.11, sa.3, ss.232-237, 2006 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 11 Sayı: 3
- Basım Tarihi: 2006
- Doi Numarası: 10.1111/j.1440-1797.2006.00562.x
- Dergi Adı: NEPHROLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.232-237
- Anahtar Kelimeler: amyloidosis, celecoxib, cyclooxygenase-2, non-steroidal anti-inflammatory drugs, proteinuria, rofecoxib, GASTROINTESTINAL TOXICITY, CARDIOVASCULAR EVENTS, RHEUMATOID-ARTHRITIS, NEPHROTIC SYNDROME, COX-2 INHIBITORS, ROFECOXIB, RESOLUTION, CELECOXIB, NAPROXEN, RISK
- Bursa Uludağ Üniversitesi Adresli: Evet
Özet
Aims: Because the cardiovascular system (CVS) side-effects of cyclooxygenase-2 (COX-2) selective inhibitors have recently been questioned, we aimed to compare the renal and haemodynamic effects of cyclooxygenase selective (celecoxib and rofecoxib) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) (indomethacin) in patients with renal amyloidosis secondary to rheumatological diseases who required anti-inflammatory agents and are taking maximum tolerable dose of angiotensin-converting enzyme inhibitors.